======= PDE1C ======= == Gene Information == * **Official Symbol**: PDE1C * **Official Name**: phosphodiesterase 1C * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5137|5137]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q14123|Q14123]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PDE1C&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PDE1C|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602987|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes an enzyme that belongs to the 3'5'-cyclic nucleotide phosphodiesterase family. Members of this family catalyze hydrolysis of the cyclic nucleotides, cyclic adenosine monophosphate and cyclic guanosine monophosphate, to the corresponding nucleoside 5'-monophosphates. The enzyme encoded by this gene regulates proliferation and migration of vascular smooth muscle cells, and neointimal hyperplasia. This enzyme also plays a role in pathological vascular remodeling by regulating the stability of growth factor receptors, such as PDGF-receptor-beta. [provided by RefSeq, Jul 2016]. * **UniProt Summary**: Cyclic nucleotide phosphodiesterase with a dual- specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes. Has a high affinity for both cAMP and cGMP. |PDEase I| |PDEase I N| |calcium- and calmodulin-regulated 3,5-cyclic-GMP phosphodiesterase activity| |calmodulin-dependent cyclic-nucleotide phosphodiesterase activity| |calmodulin binding| |neuronal cell body| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp291|LLY-284 2.6μM R06 exp291]]|-1.85| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|-1.8| |[[:results:exp263|Aphidicolin 0.04μM R06 exp263]]|1.81| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|1.84| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.02| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|2.04| |[[:results:exp64|Nocodazole 0.2μM R02 exp64]]|2.16| |[[:results:exp93|DABN racemic mixture R03 exp93]]|2.29| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|2.91| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|3.47| |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|3.64| |[[:results:exp33|Rotenone 2μM R00 exp33]]|3.82| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12114 * **Expression level (log2 read counts)**: 1.93 {{:chemogenomics:nalm6 dist.png?nolink |}}